Información de la revista
Vol. 57. Núm. 2.
Páginas 110-115 (agosto 2002)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 57. Núm. 2.
Páginas 110-115 (agosto 2002)
Acceso a texto completo
Coinfección por Chlamydia y Mycoplasma. Incidencia en nuestro medio
Coinfection with Chlamydia and Mycoplasma. Incidence in our environment
Visitas
7147
A. Megías Montijanoa, J.A. Gómez Campderáa,
Autor para correspondencia
infecc@ippp.hggm.es

Correspondencia: Sección de Infectología Pediátrica. Departamento de Pediatría. Hospital General Universitario Gregorio Marañón. Dr. Castelo, 49. 28009 Madrid. España
, M.L. Navarro Gómeza, M. Urán Morenob, M.I. González Sáncheza, R. Rodríguez Fernándezb
a Sección de Infectología Pediátrica Hospital General Universitario Gregorio Marañón. Madrid. España
b Servicio de Pediatría. Departamento de Pediatría. Hospital General Universitario Gregorio Marañón. Madrid. España
Este artículo ha recibido
Información del artículo
Objetivos

Investigar la presencia y determinar la importancia de Chlamydia pneumoniae y Mycoplasma pneumoniae como copatógenos de las neumonías comunitarias en la infancia.

Material y métodos

Estudio retrospectivo descriptivo, de todos los casos diagnosticados de neumonía por M. pneumoniae en menores de 15 años, en el servicio de urgencias de pediatría, en el período comprendido entre mayo de 1998 y mayo de 2000, investigando aquellos casos en los que se pudo demostrar la coexistencia con C. pneumoniae.

Resultados

Sobre un total de 242 neumonías diagnosticadas durante este período de tiempo, 84 fueron causadas por M. pneumoniae (34,7 %) y 32 por C. pneumoniae (13,22 %); de ellas, 8 casos presentaron coinfección por C. pneumoniae y M. pneumoniae. Existió predominio en el sexo masculino 5/8, con una edad media al diagnóstico de 7,7 años. No hubo predominio estacional.

Conclusiones

Tanto C. pneumoniae como M. pneumoniae son responsables de Neumonía Adquirida en la Comunidad en niños mayores de 5 años. A pesar del hecho de que las coinfecciones por C. pneumoniae y M. pneumoniae se acompañan normalmente de agravamiento en el curso de la enfermedad, todos los casos estudiados evolucionaron satisfactoriamente.

Palabras clave:
Coinfección
Mycoplasma
Chlamydia
Neumonía
Infancia
Objectives

To investigate the presence Mycoplasma pneumoniae and Chlamydia pneumoniae and to determine their importance as the cause of community-acquired pneumonia in childhood.

Material and methods

We performed a retrospective descriptive study of all the patients aged less than 15 years old diagnosed with community-acquired pneumonia due to M. pneumoniae in the pediatric emergency department of our hospital between May 1998 and May 2000. Patients in whom C. pneumoniae was also identified as a cause of pneumonia were investigated.

Results

Of 242 cases of community-acquired pneumonia, 82 were due to M. pneumoniae (34.7 %) and 32 were due to C. pneumoniae (13.22%). Of these, eight cases were coinfections with C. pneumoniae and M. pneumoniae. Most infections occurred in boys (5/8). The mean age at diagnosis was 7.7 years. No seasonal predominance was found.

Conclusions

Both C. pneumoniae and M. pneumoniae play a substantial role in community-acquired pneumonia in children aged more than 5 years old. Although coinfection with both species usually worsens the course of the disease, outcome in all the patients studied was satisfactory.

Key words:
Coinfection
Mycoplasma
Chlamydia
Pneumonia
Childhood
El Texto completo está disponible en PDF
Biblografía
[1.]
T. Juvén, J. Mertsola, M. Waris, M. Leinonen, O. Meurman, M. Roivainen, et al.
Etilogy of community-acquired pneumonia in 254 hospitalized children.
Pediatr Infect Dis J, 19 (2000), pp. 293-298
[2.]
G. McCracken.
Etiology and treatment of pneumonia.
Pediatr Infect Dis J, 19 (2000), pp. 373-377
[3.]
F. Del Castillo, M.J. García de Miguel, S. García.
Manejo racional de la neumonía aguda de la comunidad.
An Esp Pediatr, 51 (1999), pp. 609-916
[4.]
D. Isaacs.
Problems in determining the etiology of community-acquired childhood pneumonia.
Pediatr Infect Dis J, 8 (1989), pp. 143-148
[5.]
P. Saikku.
The epidemiology and significance of Chlamydia pneumoniae.
J Infect, 25 (1992), pp. 27-34
[6.]
J.T. Grayston.
Chlamydia pneumoniae (TWAR) infections in children.
Pediatr Infect Dis J, 13 (1994), pp. 675-685
[7.]
U. Emre, P.M. Robin, M. Gelling, W. Dumornay, M. Rao, M.R. Hammerschlag, J. Schachter.
Association of Chlamydia pneumoniae and reactive airway disease in children.
Clin Res, 40 (1992), pp. 651
[8.]
D.L. Hahn, R.W. Dodge, R. Golubjatnikov.
Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing asthmathic bronchitis, and adult-onset asthma.
JAMA, 226 (1991), pp. 225-230
[9.]
E. Norman, J. Gnarpe, B. Wettergren.
Chlamydia pneumoniae in children with acute respiratory tract infections.
Acta Paediatr, 87 (1998), pp. 23-27
[10.]
J.D. Nelson.
Community-acquired pneumonia in children: guidelines for treatment.
Pediatr Infect Dis J, 19 (2000), pp. 251-253
[11.]
J. Harris, A. Kolokathis, M. Campbell, G. Cassell, M. Hammerschlag.
Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children.
Pediatr Infect Dis J, 17 (1998), pp. 865-871
[12.]
S. Block, J. Hedrick, M. Hammerschlag, G.H. Cassell, J.C. Craft.
Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: Comparative efficacy and safety of clarithromycin vs erythromycin ethylsuccinate.
Pediatr Infect Dis J, 14 (1995), pp. 471-477
[13.]
T. Tuuminen, S. Varjo, H. Igman, T. Weber, J. Oksi, M. Viljanen.
Prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae immunoglobulin G and A antibodies in a healthy finnish population as analyzed by quantitative enzyme immunoassays.
Clin Diag Lab Immunol, 7 (2000), pp. 734-738
[14.]
J.A. Gómez Campderá, R. Rodríguez Fernández, A. Megías Montijano, M.I. González Sánchez, M. Navarro Gómez, A. Izquierdo.
Mycoplasma pneumoniae en menores de 3 años.
Acta Pediatr Esp, 57 (1999), pp. 333-335
[15.]
G. McCracken.
Diagnosis and management of pneumonia in children.
Pediatr Infect Dis J, 19 (2000), pp. 924-928
[16.]
J.A. Gómez Campderá, R. Rodríguez, M.I. González, M.L. Navarro, M. Rivera, M. Gutiérrez, R. Ramírez.
Brote epidémico de neumonía por Mycoplasma.
Rev Enferm Infec Pediatr, 58 (2001), pp. 37-48
[17.]
M. Montes, G. Cilla, M. Alcorta, E.P. Trallero.
High prevalence of Chlamydia pneumoniae infection in children and young adults in Spain.
Pediatr Infect Dis J, 11 (1992),
[18.]
T. Heiskanen-kosma, M. Korppi, A. Laurila, C. Jokinen, M. Kleemola, P. Saikku.
Chlamydia pneumoniae is an important cause of community-acquired pneumonia in school-aged children: Serological results of a prospective, population-based study.
Scand J Infect Dis, 31 (1999), pp. 255-259
[19.]
N. Principi, S. Esposito, F. Blasi, L. Allegra.
and Mowgli study group. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with Community-Adquired Lower-Respiratory Tract Infections.
Clin Infect Dis, 32 (2001), pp. 1281-1289
[20.]
J.A. Mc Millan.
Chlamydia pneumoniae revisited.
Pediatr Infect Dis J, 17 (1998), pp. 1046-1047
[21.]
T. Heiskanen-Kosma, M. Korppi, C. Jokinen, S. Kurki, L. Haiskanen, H. Juvonen.
Etiology of childhood pneumonia: Serologic results of a prospective, population-based study.
Pediatr Infect Dis J, 17 (1998), pp. 986-991
[22.]
P. Drummond, J. Clark, J. Wheeler, et al.
Community acquired pneumonia. A prospective UK study.
Arch Dis Child, 83 (2000), pp. 408-412
[23.]
M.T. Kauppinen, P. Saikku, P. Kujala, et al.
Clinical picture of community acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: A comparision between chlamydial and pneumoccocal pneumonia.
Thorax, 51 (1996), pp. 185-189
[24.]
D. Liberman, M. Ben-Yaakov, Z. Lazarovich, A. Porta, F. Schlaeffer, D. Lieberman, et al.
Chlamydia pneumoniae: A review of community acquired pneumonia of 62 hospitalized adult patients.
Infection, 24 (1996), pp. 109-114
[25.]
X. Saez Llorens, E. Castaño, L. Wubbel, M.M. Castrejon, I. De Morales, D. Vallarino, et al.
Importance of Mycoplasma pneumoniae and Chlamydia pneumoniae in children from different latitudes with community-acquired pneumonia.
Rev Med Panamá, 23 (1998), pp. 27-33
[26.]
N. Miyashita, Y. Niki, T. Matushima.
Community-Acquired Chlamydia pneumoniae pneumonia.
Chest, 117 (2000), pp. 615-616
[27.]
G. Falck, J. Gnarpe, H. Gnarpe.
Prevalence of Chlamydia pneumoniae in healthy children and in children with respiratory tract infections.
Pediatr Infect Dis J, 16 (1997), pp. 549-554
[28.]
J. Petitjean, F. Vincent, M. Fretigny, A. Vabret, J.D. Poveda, J. Brum, et al.
Comparision of two serological methods and polymerase chain reaction-enzyme immunoassay for the diagnosis of acute respiratory infections with Chlamydia pneumoniae in adults.
J Med Microbiol, 47 (1998), pp. 615-621
[29.]
L. Wubbel, L. Muñiz, A. Ahmed, M. Trujillo, C. Carubelli, C. McCoig, et al.
Etiology and treatment of community-acquired pneumonia in ambulatory children.
Pediatr Infect Dis J, 18 (1999), pp. 98-104
Copyright © 2002. Asociación Española de Pediatría
Descargar PDF
Idiomas
Anales de Pediatría
Opciones de artículo
Herramientas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?